Relative contributions of testosterone and estrogen in regulating bone resorption and formation in normal elderly men
Open accessThe DOI matches its Crossref record; 55 of the 55 references it cites were found in a registry or an index.
Abstract
Young adult males who cannot produce or respond to estrogen (E) are osteopenic, suggesting that E may regulate bone turnover in men, as well as in women. Both bioavailable E and testosterone (T) decrease substantially in aging men, but it is unclear which deficiency is the more important factor contributing to the increased bone resorption and impaired bone formation that leads to their bone loss. Thus, we addressed this issue directly by eliminating endogenous T and E production in 59 elderly men (mean age 68 years), studying them first under conditions of physiologic T and E replacement and then assessing the impact on bone turnover of withdrawing both T and E, withdrawing only T, or only E, or continuing both. Bone resorption markers increased significantly in the absence of both hormones and were unchanged in men receiving both hormones. By two-factor ANOVA, E played the major role in preventing the increase in the bone resorption markers, whereas T had no significant effect. By contrast, serum osteocalcin, a bone formation marker, decreased in the absence of both hormones, and both E and T maintained osteocalcin levels. We conclude that in aging men, E is the dominant sex steroid regulating bone resorption, whereas both E and T are important in maintaining bone formation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Both hormones are known to affect bone metabolism, but bone resorption is primarily controlled by estrogen in both sexes (Clarke & Khosla, 2010; Falahati‐Nini et al., 2000; Khosla, Melton, & Riggs, 2001).”
From Facial aging trajectories: A common shape pattern in male and female faces is disrupted after menopause (2019) · cites this paper as Falahati‐Nini et al., 2000
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“estrogen has a greater effect than androgen in inhibiting bone resorption in men”
From Pathogenesis of osteoporosis: concepts, conflicts, and prospects (2005) · cites this paper as [15]
The cited source says what the claim attributes to it.
In the citing paper
“testosterone has a direct effect on bone through the androgen receptors present in osteoblasts that enhance bone proliferation [46–50], or it has an indirect effect through the aromatization changes to estrogen [51].”
From The Effect of Tobacco Smoking on Bone Mass: An Overview of Pathophysiologic Mechanisms (2018) · cites this paper as [51]
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“To date, eight males with aromatase deficiency have been described: seven adults [17-23] and one newborn [24].”
From Aromatase inhibitors in men: effects and therapeutic options (2011) · cites this paper as [24]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“In postmenopausal women, facial aging was best predicted by the years since last menstruation and mainly attributable to bone resorption in the mandible.”
From Facial aging trajectories: A common shape pattern in male and female faces is disrupted after menopause (2019) · cites this paper as Falahati‐Nini et al., 2000
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Arky, R. A. (1994) · Cited by 2,632
Manolagas, S. C. (2000) · Endocrine Reviews · doi:10.1210/edrv.21.2.0395 · Cited by 2,568
Estrogen Resistance Caused by a Mutation in the Estrogen-Receptor Gene in a Man
Smith, E. P., Boyd, J., Frank, G. R., Takahashi, H., Cohen, R. M., Specker, B., Williams, T. C., Lubahn, D. B., & Korach, K. S. (1994) · New England Journal of Medicine · doi:10.1056/nejm199410203311604 · Cited by 2,471
Morishima, A., Grumbach, M. M., Simpson, E. R., Fisher, C., & Qin, K. (1995) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.80.12.8530621 · Cited by 1,416
Effect of testosterone and estradiol in a man with aromatase deficiency
Carani, C., Qin, K., Simoni, M., Faustini-Fustini, M., Serpente, S., Boyd, J., Korach, K. S., & Simpson, E. R. (1997) · New England Journal of Medicine · doi:10.1056/nejm199707103370204 · Cited by 1,151
Riggs, B. L., Khosla, S., & Melton, L. J. (1998) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.1998.13.5.763 · Cited by 1,143
Self-citationEstrogen promotes apoptosis of murine osteoclasts mediated by TGF–β
Hughes, D. E., Dai, A., Tiffee, J. C., Li, H. H., Mundy, G. R., & Boyce, B. F. (1996) · Nature Medicine · doi:10.1038/nm1096-1132 · Cited by 813
Estrogen, cytokines, and pathogenesis of postmenopausal osteoporosis
Pacifici, R. (1996) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650110802 · Cited by 741
Increased Bone Mass as a Result of Estrogen Therapy in a Man with Aromatase Deficiency
Bilezikian, J. P., Morishima, A., Bell, J., & Grumbach, M. M. (1998) · New England Journal of Medicine · doi:10.1056/nejm199808273390905 · Cited by 625
Endogenous Sex Steroids and Bone Mineral Density in Older Women and Men: The Rancho Bernardo Study
Greendale, G. A., Edelstein, S., & Barrett-Connor, E. (1997) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.1997.12.11.1833 · Cited by 553
Research works printed but not linked: 3
- The GLM procedure. 1990. In SAS/STAT user's guide . Sixth edition. SAS Institute Inc. Cary, North Carolina, USA. 891-996.
- Weinstein, R., et al. 1999. Like estrogen, androgens exert potent and direct anti-apoptotic effects on osteoblasts and osteocytes in vivo and in vitro. J. Bone Miner. Res. 14 (Suppl. 1):S451. (Abstr.)
- Taxel, P., and Raisz, L.G. 1997. The effect of estrogen therapy on older men with low bone mass. J. Bone Miner. Res. 12 (Suppl. 1):S353. (Abstr.)
Cited by
Items 701–756 of 756
Local and Systemic Factors in the Pathogenesis of Osteoporosis
Raisz, L. G. (2008) · Elsevier eBooks · doi:10.1016/b978-012370544-0.50040-9
The Relationship of Testosterone, Appetite, Food Intake and Exercise in Male Adolescents
Schwartz, A. (2019) · TSpace (University of Toronto)
Back, K.-A., Park, S. H., & Yoon, J. H. (2020) · Exercise Science · doi:10.15857/ksep.2020.29.2.138 · Cited by 1
“Osteocalcin의 혈청 농도는 50대 남성에서 가장 낮은 수치를 나타 내며, 성호르몬 결핍에 따라 감소된 osteocalcin은 호르몬 대체요법을 통해 정상적인 수준으로 회복될 수 있다[13].”
Anatomy and Histology of Male Skeletal Tissue: Gender Differences
Grano, M., Brunetti, G., Colaianni, G., & Colucci, S. C. (2020) · Trends in andrology and sexual medicine · doi:10.1007/978-3-319-96376-1_2 · Cited by 1
Testicular Function and Skeletal Alterations
Ferlin, A. (2020) · Trends in andrology and sexual medicine · doi:10.1007/978-3-319-96376-1_8
Physiology of Bone Mass Acquisition and Pathophysiology of Bone Mass Loss: Gender Differences
Eller-Vainicher, C., Cairoli, E., & Chiodini, I. (2020) · Trends in andrology and sexual medicine · doi:10.1007/978-3-319-96376-1_3
Osteoporosis associated with eating disorders
Robinson, L., & Misra, M. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-813073-5.00044-7
Putra, P. A. A., Susraini, A. A. A. N., & Sumadi, I. W. J. (2020) · Intisari Sains Medis · doi:10.15562/ism.v11i2.203 · Cited by 1
Bone manifestations of endocrine disease
Goltzman, D., & Kremer, R. B. (2000)
Biology and Clinical Aspects of Estrogen Action on Bone
Monroe, D. G., & Khosla, S. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-801238-3.11272-3
Self-citationOliveri, B., & Mastaglia, S. R. (2014) · Elsevier eBooks · doi:10.1016/b978-84-9022-503-5.00004-6
Bone Health and Cancer Therapy
Miedany, Y. M. E. (2022) · Springer eBooks · doi:10.1007/978-3-030-87950-1_29
Miedany, Y. M. E. (2022) · Springer eBooks · doi:10.1007/978-3-030-87950-1_25
Peate, I. (2007) · doi:10.1002/9780470697801.ch8
Miedany, Y. M. E. (2022) · Springer eBooks · doi:10.1007/978-3-030-87950-1_5 · Cited by 2
Burger, H. (2013) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.718106470.793483637
Cauley, J. A. (2012) · Springer eBooks · doi:10.1007/978-94-007-5061-6_28 · Cited by 1
Androgens, Androgen Receptor, and Bone
Colucci, S. C., & Brunetti, G. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-801238-3.11229-2
Crosstalk Between Bone and Vital Organs
Zallone, A. Z. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-801238-3.62237-7
- (2006) · Osteoporosis and Bone Diseases · doi:10.14341/osteo2006348-48
Zajac, J. D., Seeman, E., Russell, N., Ramchand, S. K., Bretherton, I., Grossmann, M., & Davey, R. A. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-801238-3.11263-2
Anti-Aging Medicine LiteratureWatch
(2001) · Rejuvenation Research · doi:10.1089/109454501750225730
Kadusauskienė, A., & Čeponis, J. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-801238-3.99466-2
(2009) · Wiley eBooks · doi:10.1002/9780470824023.refs
Nebot, E., & Pietschmann, P. (2018) · Springer eBooks · doi:10.1007/978-3-319-75110-8_13
Monroe, D. G., & Khosla, S. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-814841-9.00035-x
Self-citationMukaddam, M. A., & Snyder, P. J. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-813073-5.00078-2
Three-dimensional analysis of modeled facial aging and sexual dimorphism from juvenile to senile agePreprint
Velemínská, J., Jaklová, L. K., Kočandrlová, K., Hoffmannová, E., Koudelová, J., Suchá, B., & Dupej, J. (2022) · Research Square · doi:10.21203/rs.3.rs-1924517/v1
Role of estrogens and androgens in osteoporosis
Laurent, M. R. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-13825-6.00041-8
Billington, E. O., & Reid, I. R. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-13825-6.00043-1
Han, D., Liu, J., Wang, Y., Wang, H., Yuan, L., Jin, W., & Song, L. (2025) · Frontiers in Endocrinology · doi:10.3389/fendo.2025.1490214 · Cited by 2
“Although increasing studies suggests that estrogen may play a more signi fi cant role than androgens in male osteoporosis (58 – 60), estrogen levels in older adults males remain higher than those in postmenopausal females (61, 62).”
Kadusauskienė, A., & Čeponis, J. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-13825-6.00194-1
Alves, M. L. F., Ervolino, E., Spin‐Neto, R., Mulinari‐Santos, G., Garcia, V. G., Levin, L., & Theodoro, L. H. (2025) · Periodontal and Implant Research · doi:10.1007/s41894-025-00158-7
“Interestingly, previous in vitro studies have highlighted the negative effects of 5-FU on osteopro - genitor cells [ 22 , 23 ].”
Methadone Maintenance Treatment, Sex Hormones, and Bone Mineral Density in Persons Who Inject Drugs
Wehbeh, L., Hsu, H.-Y., Dias, J. P., Moseley, K. F., Langan, S. J., Jiang, Y., Piggott, D. A., Kirk, G. D., Dobs, A. S., Brown, T. T., et al. (2025) · Journal of the Endocrine Society · doi:10.1210/jendso/bvaf140 · Cited by 1
“The relationship between sex hormones and BMD in men is complex with contributions from both androgen and estrogen receptor signaling [38, 39].”
Ashour, L., Hammad, S., Shahwan, R., Musamih, R., Aziziye, O., Zaita, M., Fraihat, Q. A., Schumannalkhtib, A., Khreisha, M. A., Barakat, H., et al. (2025) · Hormone Molecular Biology and Clinical Investigation · doi:10.1515/hmbci-2025-0055
“These di ff erences re fl ect the critical role of estrogen de fi ciency in osteoporosis pathogenesis, with more pronounced e ff ects in women during menopause [39, 40].”
The Role of Androgens and Estrogens in the Male Skeleton
Khosla, S., & Bilezikian, J. P. (2004) · Principles of Gender-Specific Medicine · doi:10.1016/b978-012440905-7/50368-6
Self-citationPharmacotherapy Options in Cancer Treatment-induced Bone Loss: Focus on Bisphosphonates
Ito, K. (2009) · Clinical Medicine Therapeutics · doi:10.4137/cmt.s2064
Pathogenetic and diagnostic features of osteoporosis in men
Холманских, А. С., & Lesnyak, O. M. (2025) · Russian Family Doctor · doi:10.17816/rfd697563
Grimes, T. F., Pope, J., Stenning, J., Smith, T. E., Kent, D. G., Baker, S. C., Brackenbury, W. J., Willems, L. I., & Holding, A. N. (2026) · Biochemical Journal · doi:10.1042/bcj20253216
Templeton, K. J., & Geoffroy, H. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-26712-3.00013-6
Sulis, S., Falbová, D., Hozáková, A., & Vorobeľová, L. (2026) · Human Biology and Public Health · doi:10.52905/hbph2026.112
The orally available SIK2/SIK3 inhibitor SK-124 increases bone mass in hypogonadal male mice
Choi, R. B., Yoon, S.-H., Kotsalidis, P. E., Houghton, C., George, M. A., Brooks, D. J., Zhao, Y., Bouxsein, M., & Wein, M. N. (2026) · JBMR Plus · doi:10.1093/jbmrpl/ziag032 · Cited by 1
“2,33 34–36 Disrupted bone remodeling by reduced sex steroid levels leads to increased bone resorption and decreased bone formation, resulting in a net loss of bone mass and strength.”
Role of bone microarchitecture and hereditary determinants of bone fragility
Nagy, H. A. A. M. (2013) · theses.fr (ABES) · doi:10.70675/950dc642z816dz4693za1e6za963d3d33fff
Baek, D.-C., Chae, M.-Y., Woo, T.-W., Son, C.-G., & Lee, E. J. (2026) · Pharmaceuticals · doi:10.3390/ph19040555
Čeponis, J., Wang, C., Swerdloff, R., & Liu, P. Y. (2026) · Endocrinology · doi:10.1007/978-3-319-29456-8_11-2 · Cited by 1
Tramontana, F., & Quinton, R. (2026) · Endocrinology and Metabolism · doi:10.3803/enm.2026.2955
“In contrast to women, the risk of fragility fractures develops much later in life, in parallel to the age-related decline in both T levels and erythropoietic activity [2,3].”
Sex Differences in Bone: Considerations for Biomaterial Design
Tiffany, A. S., & Kolliopoulos, V. (2026) · Springer eBooks · doi:10.1007/978-3-032-10745-9_14
Hypogonadism and Metabolic Disorders
Cignarelli, A., Genchi, V. A., & Jayasena, C. N. (2026) · Endocrinology · doi:10.1007/978-3-319-29456-8_50-1 · Cited by 1
Wang, Y., Li, A., Wang, J., & Xie, M. (2026) · Journal of International Medical Research · doi:10.1177/03000605261463660
“29 Additionally, in men, circulating estradiol levels were found to have a stronger correlation with bone mineral density than circulating testosterone levels.”
Aging of the Human Skeleton and its Contribution to Osteoporotic Fractures
Kassem, M. S., Brixen, K., & Mosekilde, L. (2003) · Springer eBooks · doi:10.1007/978-94-017-0673-5_5
Osteoporosi nelle malattie endocrine
Cianferotti, L., & Marcocci, C. (2009) · Springer eBooks · doi:10.1007/978-88-470-1357-5_13
Metadata
- Authors
- Falahati-Nini, A., Riggs, B. L., Atkinson, E. J., O’Fallon, W. M., Eastell, R., & Khosla, S.
- Affiliations
- Mayo Clinic (US)
- Corresponding author
- Khosla, Sundeep
- Venue
- Journal of Clinical Investigation
- Published
- 2000-12-15
- Volume
- 106
- Issue
- 12
- Pages
- 1553-1560
- ISSN
- 0021-9738 (ISSN-L)
- PMC
- PMC381474
- OpenAlex
- W2144000500
- Cited by
- 757
- References
- 55
- Citations by year
- 2026: 11 · 2025: 17 · 2024: 17 · 2023: 16 · 2022: 24 · 2021: 21 · 2020: 28 · 2019: 28 · 2018: 25 · 2017: 22 · 2016: 34 · 2015: 23 · 2014: 28 · 2013: 31 · 2012: 28
- FWCI
- 29.12
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Journal of Clinical Investigation (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Deutsches Krebsforschungszentrum
- National Institutes of Health (AG 04875, RR-00585)
- National Institute on Aging (AG 04875, P01AG004875)
- National Center for Research Resources (RR-00585, M01RR000585)
- Topics
- Health Sciences › Medicine › Orthopedics and Sports Medicine › Bone health and osteoporosis research
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal and reproductive studies
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Bone Metabolism and Diseases
- Keywords
- testosterone, estrogen, bone resorption, bone formation, bone turnover, older men, osteopenia, osteocalcin, sex steroids, hormone replacement therapy, bone loss
- MeSH terms
- Aged, Aging, Analysis of Variance, Anthropometry, Bone Resorption, Estrogens, Humans, Male, Testosterone, Biomarkers, Bone Density, Osteocalcin
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.